Laura Cattaneo Selected Research

Laura Cattaneo Research Topics

Disease

12	Neoplasms (Cancer) 05/2024 - 01/2014
3	Neoplasm Metastasis (Metastasis) 05/2024 - 01/2020
3	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 01/2020
2	Inflammation (Inflammations) 01/2024 - 10/2021
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 09/2022
2	Carcinoma (Carcinomatosis) 01/2020 - 08/2013
2	Melanoma (Melanoma, Malignant) 11/2019 - 01/2017
2	Lymphoma (Lymphomas) 02/2018 - 01/2018
1	Hyperthermia 05/2024
1	Adenoma (Adenomas) 01/2024
1	Seminoma 08/2023
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2023
1	Small Cell Carcinoma 09/2022
1	Adenocarcinoma 09/2022
1	Carcinoid Tumor (Carcinoid) 09/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2022
1	Pathologic Complete Response 01/2021
1	Disease Progression 01/2021
1	Merkel Cell Carcinoma 01/2021
1	Skin Neoplasms (Skin Cancer) 01/2021
1	Infratentorial Neoplasms (Posterior Fossa Tumors) 01/2021
1	Tics (Tic) 07/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Neuroendocrine Carcinoma 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Myocardial Infarction 01/2011
1	ST Elevation Myocardial Infarction 01/2011
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2005

Drug/Important Bio-Agent (IBA)

3	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2019
2	LigandsIBA 07/2020 - 01/2014
2	B7-H1 AntigenIBA 01/2020 - 01/2017
2	CateninsIBA 11/2019 - 01/2017
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2019 - 01/2017
2	TenascinIBA 02/2018 - 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2024
1	Decellularized Extracellular MatrixIBA 01/2023
1	chlorambucil-oleic acid conjugateIBA 09/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2021
1	15-hydroxyprostaglandin dehydrogenaseIBA 10/2021
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 10/2021
1	avelumabIBA 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	Lomustine (CCNU)FDA Link 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Vincristine (Oncovin)FDA LinkGeneric 01/2021
1	Histocompatibility Antigens Class IIBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 07/2020
1	HLA-DR Antigens (HLA-DR)IBA 07/2020
1	Programmed Cell Death 1 ReceptorIBA 07/2020
1	Cetuximab (Erbitux)FDA Link 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Anaplastic Lymphoma KinaseIBA 01/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 01/2020
1	Capecitabine (Xeloda)FDA Link 01/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2019
1	Glycoproteins (Glycoprotein)IBA 02/2018
1	ParaffinIBA 01/2017
1	Formaldehyde (Formol)FDA Link 01/2017
1	Matrix Metalloproteinases (MMPs)IBA 01/2017
1	Mitogen-Activated Protein KinasesIBA 01/2017
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2017
1	Monoclonal AntibodiesIBA 01/2014
1	SERPIN-B5 (maspin)IBA 08/2013
1	Protein Isoforms (Isoforms)IBA 07/2005

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2011
3	Drug Therapy (Chemotherapy) 05/2024 - 01/2021
2	Mediterranean Diet 01/2024 - 10/2021
2	Radiotherapy 08/2023 - 01/2019
2	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 01/2023
2	Colectomy 07/2022 - 01/2022
2	Radioimmunotherapy 02/2018 - 01/2018
1	Hyperthermic Intraperitoneal Chemotherapy 05/2024
1	Immunotherapy 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Craniospinal Irradiation 01/2021
1	Adjuvant Radiotherapy 01/2020
1	Percutaneous Coronary Intervention 01/2011